ARMATA PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$40.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-11-14
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$33.00K.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$2.00K.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$5.00K.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$13.00K.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$279.00K.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$210.00K.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$1.20M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2017-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$35.00K derived: sum of 2 quarters · filed 2017-11-14 | -$40.00K 10-Q · filed 2017-11-14 | -$53.00K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2017-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$7.00K 10-Q · filed 2017-08-14 | -$20.00K derived: sum of 3 quarters · filed 2017-08-14 | -$49.00K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2017-03-31 | -$5.00K 10-Q · filed 2017-05-15 | -$18.00K derived: sum of 2 quarters · filed 2017-05-15 | -$47.00K derived: sum of 3 quarters · filed 2017-11-14 | -$172.00K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | -$42.00K derived: sum of 2 quarters · filed 2017-11-14 | -$167.00K derived: sum of 3 quarters · filed 2017-11-14 | -$279.00K 10-K · filed 2017-03-27 | |
| 2016-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$154.00K derived: sum of 2 quarters · filed 2017-11-14 | -$266.00K 10-Q · filed 2017-11-14 | -$316.00K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$237.00K 10-Q · filed 2017-08-14 | -$287.00K derived: sum of 3 quarters · filed 2017-08-14 | -$403.00K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | -$112.00K 10-Q · filed 2017-05-15 | -$162.00K derived: sum of 2 quarters · filed 2017-05-15 | -$278.00K derived: sum of 3 quarters · filed 2017-05-15 | -$287.00K derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | -$166.00K derived: sum of 2 quarters · filed 2017-03-27 | -$175.00K derived: sum of 3 quarters · filed 2017-03-27 | -$210.00K 10-K · filed 2017-03-27 | |
| 2015-09-30 | -$116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$125.00K derived: sum of 2 quarters · filed 2016-11-10 | -$160.00K 10-Q · filed 2016-11-10 | -$165.00K derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$44.00K 10-Q · filed 2016-08-15 | -$49.00K derived: sum of 3 quarters · filed 2016-08-15 | -$186.00K derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | -$35.00K 10-Q · filed 2016-05-12 | -$40.00K derived: sum of 2 quarters · filed 2016-05-12 | -$177.00K derived: sum of 3 quarters · filed 2016-05-12 | -$1.01M derived: sum of 4 quarters · filed 2016-05-12 | |
| 2014-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$142.00K derived: sum of 2 quarters · filed 2016-03-30 | -$973.00K derived: sum of 3 quarters · filed 2016-03-30 | -$1.20M 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$968.00K derived: sum of 2 quarters · filed 2015-11-16 | -$1.20M 10-Q · filed 2015-11-16 | -$1.09M 10-Q · filed 2014-11-14 | -$1.20M derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | -$831.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$1.06M 10-Q · filed 2015-08-13 | -$1.06M derived: sum of 3 quarters · filed 2015-08-13 | -$1.10M derived: sum of 4 quarters · filed 2015-08-13 | |
| 2014-03-31 | -$229.00K 10-Q · filed 2015-05-15 | -$234.00K derived: sum of 2 quarters · filed 2015-05-15 | -$266.00K derived: sum of 3 quarters · filed 2015-05-15 | -$331.00K derived: sum of 4 quarters · filed 2015-05-15 | |
| 2013-12-31 | -$5.00K derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15 | -$37.00K derived: sum of 2 quarters · filed 2015-04-15 | -$102.00K derived: sum of 3 quarters · filed 2015-04-15 | -$102.00K 10-Q/A · filed 2015-04-15 | |
| 2013-09-30 | -$32.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-04-15 | -$97.00K derived: sum of 2 quarters · filed 2015-04-15 | -$97.00K 10-Q/A · filed 2015-04-15 | ||
| 2013-06-30 | -$65.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-04-15 | -$65.00K 10-Q/A · filed 2015-04-15 | |||
| 2013-03-31 | $0.00 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |